Accessibility Menu
ICU Medical logo

ICU Medical(NASDAQ) ICUI

Market Cap$4.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+3,795%
5 Year-10%
1 Year+38%
1 Month+6%
Premium Feature
Moneyball Superscore
53/100
$175.10
-2.50%
-4.49Today
ICU Medical last closing stock price
MetricPriceDate
Last closeUSD 175.102026-08-27
ICU Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.07%USD 182.532026-08-20
1 month+5.63%USD 165.782026-07-28
3 month+29.33%USD 135.392026-05-29
Year to date+22.73%USD 142.672025-12-31
1 year+38.29%USD 126.622025-08-27
3 year+26.45%USD 138.472023-08-28
5 year-10.22%USD 195.032021-08-27
Since inception+3,794.72%USD 4.611992-03-31

ICU Medical Financials at a Glance

Market Cap

$4.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.16B

Net Income (TTM)

$30.09M

EPS (TTM)

$1.18

P/E Ratio

147.91

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$175.10

Volume

263,687.82

Open

$177.49

Previous Close

$175.10

Daily Range

$174.88 - $179.07

52-Week Range

$112.50 - $192.85

Estimated Earnings Date

Nov 5, 2026

ICUI: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ICU Medical

ICU Medical, Inc. helps hospitals deliver medicine to patients safely. The company makes infusion pumps and other medical supplies. Doctors and nurses use these tools in critical care settings.

Essential Supplies and Systems

  • Consumables: Medical tubing, connectors, and catheters for drug delivery; generated $289.3 million in revenue during the quarter ended June 30, 2026.
  • Infusion Systems: Smart pumps and safety software that deliver fluids and medicine; accounted for $189.0 million in revenue for the quarter ended June 30, 2026.
  • Vital Care: Monitoring systems and anesthesia tools for critical hospital settings; produced $73.4 million in revenue for the quarter ended June 30, 2026.

Big Moves and New Partnerships

  • Formed a joint venture with Otsuka Pharmaceutical Factory in May 2025 to manage the IV Solutions product line.
  • Sold a 60% interest in the IV Solutions business for $211.2 million in the second quarter of 2025.
  • Received FDA clearance for the Plum Duo and Plum Solo precision infusion pumps in April 2025.
  • Agreed to sell certain business assets in March 2026 and received an initial $2 million deposit.

What Makes ICU Medical Stand Out?

ICU Medical connects its smart pumps to hospital electronic records using proprietary software to help reduce medication errors. The company employs 13,000 people and maintains a global distribution network serving hospitals and outpatient clinics.

How the Numbers Stack Up

  • Consumables revenue was $289.3 million in the quarter ended June 30, 2026, up 5.9% year over year.
  • Infusion Systems revenue reached $189.0 million for the three-month period ended June 30, 2026, up 12.7% year over year.
  • Gross margin reached 42.6% in the second quarter of 2026, up from 37.9% year over year.
  • Cash and cash equivalents totaled $298.3 million as of June 30, 2026.

Bottom Line

ICU Medical has shifted its strategy toward higher-value infusion systems and consumables while divesting majority control of its IV solutions line. Its focus on integrating smart hardware with safety software supports its role in modern hospital environments.

AI Generated • Aug 7, 2026

Industry

Healthcare Equipment and Supplies

Employees

13,000

CEO

Vivek Jain

Headquarters

San Clemente, CA 92673, US

ICUI Financials

Key Financial Metrics (TTM)

Gross Margin

37.56%

Operating Margin

5.04%

Net Income Margin

1.39%

Return on Equity

1.41%

Return on Capital

3.04%

Return on Assets

0.76%

Earnings Yield

0.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

25.01M

Volume

263.69K

Avg. Volume

305.25K

Financials (TTM)

Gross Profit

$811.16M

Operating Income

$108.76M

EBITDA

$297.64M

Operating Cash Flow

$236.37M

Capital Expenditure

-$83.54M

Free Cash Flow

$152.83M

Cash & ST Invst.

$298.30M

Total Debt

$1.27B

ICU Medical Performance Analysis

ICU Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,276,168,00072.9%
20232023-12-31USD 2,258,830,000-0.8%
20242024-12-31USD 2,379,065,0005.3%
20252025-12-31USD 2,230,025,000-6.3%
ICU Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-2.2%
Q42025-12-310.6%
Q12026-03-31-1.8%
Q22026-06-304.0%
ICU Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3.11N/A
20232023-12-31USD -1.23-60.4%
20242024-12-31USD -4.83292.0%
20252025-12-31USD 0.03N/A
ICU Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-109.8%
Q42025-12-31-357.1%
Q12026-03-31287.5%
Q22026-06-30-36.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$551.68M

+0.5%

Gross Profit

$235.05M

+13.0%

Gross Margin

42.61%

N/A

Market Cap

$4.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$336.83K

N/A

Employees

13,000

N/A

Net Income

$19.09M

-46.0%

EBITDA

$141.34M

+32.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$298.30M

-0.6%

Total Debt

$1.27B

-8.5%

Accounts Receivable

$218.64M

-0.2%

Inventory

$607.42M

-1.5%

Long Term Debt

$1.25B

-9.9%

Short Term Debt

$18.75M

N/A

Return on Assets

0.76%

N/A

Return on Invested Capital

3.13%

N/A

Free Cash Flow

$61.64M

+671.0%

Operating Cash Flow

$80.15M

+614.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIVNLivaNova PLC
$80.03+0.08%
HTFLHeartflow, Inc. Common Stock
$48.10-1.72%
HAEHaemonetics Corporation
$105.00-1.50%
IRONDisc Medicine, Inc.
$82.55-0.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.35-0.06%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$123.05+0.06%
NVDANvidia
$227.98+0.09%
IRENIren
$40.53+0.02%

Questions About ICUI

What is the current price of ICU Medical?

ICU Medical is trading at $175.10 per share.

What is the 52-week range for ICU Medical?

Over the past 52 weeks, ICU Medical has traded between $112.50 and $192.85.

How much debt does ICU Medical have?

As of the most recent reporting period, ICU Medical reported total debt of $1.29B.

How much cash does ICU Medical have on hand?

ICU Medical reported $298.30M in cash and cash equivalents in its most recent financial results.

What is ICU Medical’s dividend yield?

ICU Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.